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Abstract 
Little is known about the role of certain viruses, such as parainfluenza virus type 4 (HPIV-4) in the etiology of respiratory infections. The objective of this study 
is to present preliminary data on respiratory infections associated with HPIV-4 in children living in the city of Fortaleza capital of the state of Ceará, Brazil. A 
set of 846 samples of nasopharyngeal aspirates collected during four years from children with acute respiratory infections were submitted to direct 
immunofluorescence for the detection of HPIV-4. Fifteen HPIV-4 were detected. Cases of the upper respiratory infections, bronchiolitis and pneumonia were 
associated to this virus. Further studies are needed to clarify the clinical significance of HPIV-4 infections.  
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Introduction 
Human parainfluenza viruses (HPIV) are important 
human respiratory pathogens of upper or lower 
respiratory infections in children previously healthy or 
not [1-3]. It is estimated that 6.8% to 10% of 
hospitalizations for acute respiratory infections in 
children are due to HPIV overall [1]. They belong to the 
family Paramyxoviridae, genera Respirovirus (HPIV-1 
and HPIV-3) and Rubulavirus (HPIV-2 and HPIV-4) [4]. 
There are two HPIV-4 subtypes: HPIV-4a and HPIV-4b.  
Studies on HPIV have primarily focused on HPIV-1 
to 3 and little is known about HPIV-4. Monoclonal 
antibody specific for this virus is not included in the 
commercially available immunofluorescence kits 
generally used in research or for respiratory virus 
surveillance systems. In addition, another possible 
explanation for the limited information on HPIV-4 is its 
difficulty in isolation in cell culture. The use of 
molecular biology methods for the detection of HPIV-4 
in human respiratory infections has brought more 
information on the participation of this virus [3,5-15]. 
HPIV-4 has been frequently associated with cases of 
mild respiratory infections, which has limited knowledge 
about the pathogenic potential of this virus. More 
recently, however, HPIV-4 has been detected in cases of 
croup, bronchiolitis and pneumonias in hospitalized 
patients [12-15].  
The aim of this study was to show preliminary 
epidemiology and clinical data of HPIV-4 infections in 
children living in the city of Fortaleza, Northeast Brazil. 
 
Methods 
From January 2008 to December 2011 a total of 
3,534 nasopharyngeal aspirates were collected from 
children who attended Hospital Infantil Albert Sabin 
(HIAS) with complaints of respiratory tract infections. 
The HIAS is a teaching, public care, tertiary-level and 
reference hospital for children and adolescents. This 
health facility is located in the city of Fortaleza, the 
capital of Ceará state (northeast Brazil), at 3o 43’S, 38o 
32’ W, at sea level. The localization of Fortaleza in the 
Brazilian territory is showed in the Figure 1. 
All samples were submitted beforehand to indirect 
immunofluorescence assay (IFA) for respiratory 
syncytial virus, influenza A and B, adenovirus and 
parainfluenza virus 1, 2 and 3, as described previously.16 
For this study, only samples with a negative IFA result 
were used. A set of 846 samples randomly selected were 
submitted to a direct immuofluorescence assay (DFA) 
using a fluorescein isothiocyanate-conjugated 
monoclonal antibody against HPIV-4 (Millipore, Light 
DiagnosticsTM ®, Temecula, California, US) following 
manufacturer’s instruction. 
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Figure 1. Location of Fortaleza, city where the study was carried out, 
in the Brazilian territory. 
 
 
A database of the study population was created with 
information obtained during child care in emergence 
room or from their medical records when they were 
hospitalized. This study was approved by the 
Institutional Review Board of the HIAS. Written 
informed consent was obtained from all participants in 
the study (024/2013). 
 
Results 
In the 3534 samples analyzed by the IFA 755 viruses 
were detected, considering both, single and multiple 
infections. The detected viruses were 339 RSV, 180 
HPIV: 42 HPIV-1, 24 HPIV-2 and 114 HPIV-3, 151 
influenza: 143 influenza A and 8 influenza B, and 85 
adenovirus.  
Samples in which HPIV-4 was tested represented 
24% of all samples submitted to IFA and 30.4% of those 
that presented negative results by this method. HPIV-4 
was detected in 15 samples, representing 1.7% of the 
samples analyzed. Table 1 shows the total of samples 
analyzed by IFA and DFA in the four years of study, as 
well as viruses detected by each method. 
HPIV-4 positive samples were predominantly from 
male children (66.6%), aged 2 to 24 months (80%), who 
were not hospitalized (93.3%). Patients treated for upper 
respiratory tract infections (URTI) accounted for 77.3% 
of the positive cases for HPIV-4. Three of these patients 
were admitted to the hospital emergency department 
during an asthmatic crisis after the onset of URTI.  
Bronchiolitis was the most prevalent diagnosis of the 
lower respiratory tract infections, followed by 
pneumonia. Although most patients infected with HPIV-
4 did not have underlying diseases, three of them were 
asthmatic and one had congenital heart disease. The latter 
presented bronchiolitis, being the only admitted.  
 
Table 1. Viruses detected in the study. 
  
IFA= indirect immunofluorescence assay; DFA= direct immunofluorescence 
assay; HPIV= human parainfluenza virus; RSV= respiratory syncytial virus. 
 
Table 2. Clinical and epidemiological aspects of acute respiratory 
infections caused by human parainfluenza virus type 4. 
 
URTI: upper respiratory tract infections. 
 
All patients who presented positive respiratory 
infection for HPIV-4 evolved without complications, 
even the hospitalized one. The table 2 shows the 
epidemiological and clinical characteristics of children 
with respiratory infections positive for HPIV-4. 
 
Discussion 
The use of DFA in the present study resulted in an 
HPIV-4 detection rate of 1.7%. This technique has been 
used to detect HPIV-4 directly in clinical samples or as a 
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method of confirming isolation of this virus in cell 
culture. The use of IFA in the identification of respiratory 
viruses has been greatly reduced with the introduction of 
molecular diagnostic methods, however it is still used by 
respiratory virus surveillance systems in several 
countries, including Brazil [17,18]. However, HPIV-4 is 
not comprised in the pool of viruses screened in the 
commercially available immunofluorescence kits. 
Laboratory surveillance for HPIV infections in England 
and Wales from 1975 to 1997 detected 88 HPIV-4, 
however the HPIV identification method only became 
available after 1988 when DFA accounted for 51 of the 
70 HPIV- 4 reports [19]. HPIV-4 was the only virus 
detected in a respiratory infection outbreak that occurred 
in a facility for children with developmental disabilities 
[20]. All forty-one cases investigated were detected by 
RT-PCR whereas DFA detected only 29 of 39 tested 
cases. The sensitivity of immunofluorescence varies 
substantially among HPIV that are routinely screened by 
it.  
Among HPIV overall, there is wide range of the type 
detected; however, most studies report a predominance 
of HPIV-3 and HPIV-1 [5,7,8,13]  HPIV-4 has been 
detected in rates that ranged from less than 1% to 
3%.3,6,8,10,11,12,14,15  In two studies HPIV-4 was the 
most detected HPIV [3,11]. One of these studies was 
conducted with adults patients [11].  
Our results suggest the possibility of HPIV-4 be 
more frequently detected than other viruses. Comparing 
the number of HPIV-4 and influenza B detected in three 
years (2008, 2009, 2011), HPIV-4 exceeded the number 
of influenza B. In relation to other types of HPIV, the 
circulation of HPIV-2 was similar to that of HPIV-4 in 
two years (2008, 2010). The most frequent detection of 
HPIV-4 in relation to HPIV-2 has been reported in 
several studies [3,6,8,10,11,12,14]. In addition to the 
small number of analyzed samples, another factor that 
may have determined the small number of HPIV-4 
detected was the fact that we used only negative samples 
for the other viruses analyzed by IFA.  
Other reports have shown that HPIV-4 has been 
frequently detected in co-infection with other respiratory 
viruses [5,6,8,10]. 
These are preliminary data on clinical and 
epidemiological features of HPIV-4 infections in 
children living in a city of northeast Brazil. However, 
HPIV-4 was included among the viruses investigated in 
some Brazilian studies [14,21, 22]. The rate of detection 
of HPIV-4 detection was not reported in one of them 
[22]. The frequency order of HPIVs in the present study 
was similar to that reported in one of the studies carried 
out in the city of São Paulo [14]. 
The data presented here showed that this virus can be 
detected in patients diagnosed with different syndromes, 
including bronchiolitis and pneumonia, although the 
majority of cases were considered mild, and managed as 
outpatient. Three patients in whom HPIV-4 was detected 
were admitted to the emergency room due to asthmatic 
crisis-related symptoms following the onset of upper 
airway infection. In this way, this is another virus whose 
infection by it may be associated with an asthma 
exacerbation in children, which is well known with other 
viruses [23]. 
HPIV have been pointed out as second leading cause 
of hospitalization due to viral respiratory infections in 
young children in the United States of America [1]. 
Bronchiolitis was diagnosed in three patients positive for 
HPIV-4, one of them required hospitalization. This case 
occurred in a patient who had a congenital heart disease 
as the underlying disease. The detection of HPIV-4 in 
two patients with congenital heart disease was also 
reported in a study carried out in another Brazilian city 
[21]. In a previous study performed with children living 
in Fortaleza, 12% of the children positive for HPIV (1, 2 
and 3) were hospitalized [16]. There is increasing 
publication of studies showing the association of HPIV-
4 to cases of severe respiratory infections in previously 
healthy or immunocompromised patients, which 
contradicts the previous idea that this virus was 
associated only with cases of mild infections [8, 
10,14,15,24,25]. 
Considering that the set of samples submitted to 
DFA were not representative of a continuous collection 
over the four years, it was not possible to establish a 
pattern of seasonality to the HPIV-4 in Fortaleza, as 
previously described for other HPIV [16]. 
Despite its limitations, this study contributes to a 
better understanding of viral respiratory infections by 
adding the first information about of HPIV-4 in 
respiratory infections in children living in the Brazilian 
Northeast. Further studies are needed to expand our 
understanding of the epidemiology and clinical impact of 
HPIV-4 infections in patients of higher ages. 
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